Comparison of transfusion rates between robotic- and video-assisted lobectomy: a propensity score matching analysis.


Journal

Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 24 07 2023
accepted: 01 09 2023
medline: 28 11 2023
pubmed: 16 9 2023
entrez: 15 9 2023
Statut: ppublish

Résumé

The objective is to compare the perioperative blood transfusion rate and postoperative complications between robot-assisted surgery and thoracoscopic surgery in lung cancer patients. This is a single-center retrospective study. Patients underwent lung cancer minimally invasive resection at Fujian Cancer Hospital from April 1, 2022, to April 30, 2023, were enrolled in this study. Patients were divided into robotic-assisted lobectomy (RAL) and video-assisted lobectomy (VAL) groups according to the surgical methods. Data, including demographics, clinic variables, and endpoint outcomes were collected from the electronic medical record. Propensity score matching (PSM) was performed to analyze the baseline data of patients. The RAL group and the VAL group were matched 1:1. Then, the blood transfusion rates and short-term outcomes of the two groups were compared. A logistic regression was performed to analyze the independent risk factors of perioperative blood transfusion. A total of 558 patients were enrolled in this study. 166 of 558 patients were divided into the RAL group, and 392 patients were into the VAL group. A total of 118 patients were selected and analyzed following propensity score matching. After PSM, there was no difference in perioperative transfusion rates, including RBC transfusion and frozen plasma transfusion, between the VAL and RAL groups (P > 0.05). The RAL group had fewer days of drainage tubes (P = 0.036). There was no difference in other short-term outcomes, including the volume of thoracic drainage, the volume of intraoperative blood loss, the length of hospitalization, and the rate of postoperative pulmonary infection (P > 0.05). Volume of intraoperative blood loss, volume of thoracic drainage, and preoperative hemoglobin were independent risk factors of perioperative red blood cell or frozen plasma transfusion; however, RAL or VAL was not. The study showed that the rates of perioperative blood transfusion were comparable between RAL and VAL. RAL is superior for patient recovery in terms of short-term outcomes.

Identifiants

pubmed: 37715086
doi: 10.1007/s11701-023-01712-w
pii: 10.1007/s11701-023-01712-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2773-2781

Subventions

Organisme : Natural Science Foundation of Fujian Province
ID : 2022J011050
Organisme : Natural Science Foundation of Fujian Province
ID : 2020J011110
Organisme : Joint Funds for the innovation of science and Technology, Fujian province
ID : 2021Y9205

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

Références

Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
doi: 10.3322/caac.21660 pubmed: 33538338
Demmy TL, Yendamuri S, D’Amico TA et al (2018) Oncologic equivalence of minimally invasive lobectomy: the scientific and practical arguments. Ann Thorac Surg 106(2):609–617
doi: 10.1016/j.athoracsur.2018.02.089 pubmed: 29678519
Augustin F, Schmid T, Sieb M et al (2008) Video-assisted thoracoscopic surgery versus robotic-assisted thoracoscopic surgery thymectomy. Ann Thorac Surg 85(2):S768–S771
doi: 10.1016/j.athoracsur.2007.11.079 pubmed: 18222214
van Boxel GI, Kingma BF, Voskens FJ et al (2020) Robotic-assisted minimally invasive esophagectomy: past, present and future. J Thorac Dis 12(2):54–62
doi: 10.21037/jtd.2019.06.75 pubmed: 32190354 pmcid: 7061186
Peters BS, Armijo PR, Krause C et al (2018) Review of emerging surgical robotic technology. Surg Endosc 32(4):1636–1655
doi: 10.1007/s00464-018-6079-2 pubmed: 29442240
O’Sullivan KE, Kreaden US, Hebert AE et al (2019) A systematic review and meta-analysis of robotic versus open and video-assisted thoracoscopic surgery approaches for lobectomy. Interact Cardiovasc Thorac Surg 28(4):526–534
doi: 10.1093/icvts/ivy315 pubmed: 30496420
Zhang F, Xu L, Lu H et al (2022) Short-term surgical outcomes for lobectomy between robot-assisted thoracic surgery and uniportal video-assisted thoracoscopic surgery. Front Oncol 12:914059
doi: 10.3389/fonc.2022.914059 pubmed: 35912191 pmcid: 9326123
Sun TY, Xie CL, Tan Z et al (2023) Short-term outcomes of robotic lobectomy versus video-assisted lobectomy in patients with pulmonary neoplasms. Thorac Cancer 14(16):1512–1519
doi: 10.1111/1759-7714.14895 pubmed: 37128686 pmcid: 10234776
Miyajima M, Maki R, Arai W et al (2022) Robot-assisted vs. video-assisted thoracoscopic surgery in lung cancer. J Thorac Dis 14(6):1890–1899
doi: 10.21037/jtd-21-1696 pubmed: 35813736 pmcid: 9264105
Jin R, Zheng Y, Yuan Y et al (2022) Robotic-assisted versus video-assisted thoracoscopic lobectomy: short-term results of a randomized clinical trial (RVlob Trial). Ann Surg 275(2):295–302
doi: 10.1097/SLA.0000000000004922 pubmed: 33938492
Pan H, Zhang J, Tian Y et al (2023) Short- and long-term outcomes of robotic-assisted versus video-assisted thoracoscopic lobectomy in non-small cell lung cancer patients aged 35 years or younger: a real-world study with propensity score-matched analysis. J Cancer Res Clin Oncol 388:489
Kent MS, Hartwig MG, Vallieres E et al (2023) Pulmonary open, robotic, and thoracoscopic lobectomy (PORTaL) study: an analysis of 5721 cases. Ann Surg 277(3):528–533
doi: 10.1097/SLA.0000000000005115 pubmed: 34534988
Lampridis S, Maraschi A, Le Reun C et al (2023) Robotic versus video-assisted thoracic surgery for lung cancer: short-term outcomes of a propensity matched analysis. Cancers (Basel) 15(8):2391
doi: 10.3390/cancers15082391 pubmed: 37190319
Luan H, Ye F, Wu L et al (2014) Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis. BMC Surg 14:34
doi: 10.1186/1471-2482-14-34 pubmed: 24884867 pmcid: 4057617
Latif MJ, Tan KS, Molena D et al (2019) Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 157(6):2469-2477.e10
doi: 10.1016/j.jtcvs.2018.12.109 pubmed: 30902468 pmcid: 6626561
Marec F, Socha R, Gelbic I (1987) Mutagenicity testing of the juvenoid methoprene (ZR-515) by means of the Drosophila wing spot test. Mutat Res 188(3):209–214
doi: 10.1016/0165-1218(87)90091-7 pubmed: 3110612
Ghaly G, Kamel M, Nasar A et al (2016) Video-assisted thoracoscopic surgery is a safe and effective alternative to thoracotomy for anatomical segmentectomy in patients with clinical stage i non-small cell lung cancer. Ann Thorac Surg 101(2):465–472
doi: 10.1016/j.athoracsur.2015.06.112 pubmed: 26391692
Nwogu CE, D’Cunha J, Pang H et al (2015) VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance). Ann Thorac Surg 99(2):399–405
doi: 10.1016/j.athoracsur.2014.09.018 pubmed: 25499481
Wang T, Luo L, Huang H et al (2014) Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg 97(5):1827–1837
doi: 10.1016/j.athoracsur.2013.12.044 pubmed: 24674755
Cho S, Park J, Lee M et al (2021) Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis. Transl Lung Cancer Res 10(4):1700–1710
doi: 10.21037/tlcr-20-933 pubmed: 34012786 pmcid: 8107741
Panagopoulos ND, Karakantza M, Koletsis E et al (2008) Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer. Lung Cancer 62(2):273–280
doi: 10.1016/j.lungcan.2008.02.025 pubmed: 18430486
Stoleriu MG, Gerckens M, Zimmermann J et al (2023) Preoperative risk factors predict perioperative allogenic blood transfusion in patients undergoing primary lung cancer resections: a retrospective cohort study from a high-volume thoracic surgery center. BMC Surg 23(1):44
doi: 10.1186/s12893-023-01924-9 pubmed: 36849951 pmcid: 9972742
Pan H, Gu Z, Tian Y et al (2022) Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older. Front Oncol 12:1009298
doi: 10.3389/fonc.2022.1009298 pubmed: 36185241 pmcid: 9525021
Lanigan M, Wilkey A (2023) Current concepts in evaluation and management of preoperative anaemia in patients undergoing thoracic surgery. Curr Opin Anaesthesiol 36(1):89–95
doi: 10.1097/ACO.0000000000001214 pubmed: 36550609

Auteurs

Jingfu Liu (J)

Department of Blood Transfusion, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, China, 350014.

Jiayi Shi (J)

Fuding Panxi Health Center, No.68 Wenkui Road, Panxi Town, Ningde, 355213, China.

Zhen Li (Z)

Department of Blood Transfusion, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, China, 350014.

Shan Chen (S)

Department of Blood Transfusion, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, China, 350014.

Xianren Ye (X)

Department of Blood Transfusion, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, China, 350014. yexianren260117@fjmu.edu.cn.
Department of Laboratory Medicine, The School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China. yexianren260117@fjmu.edu.cn.
Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, China. yexianren260117@fjmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH